NASDAQ:NAUT
Nautilus Biotechnology, Inc. Stock News
$2.78
+0.240 (+9.45%)
At Close: May 01, 2024
Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript
01:13pm, Wednesday, 28'th Feb 2024
Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
08:00am, Wednesday, 07'th Feb 2024
SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript
11:22am, Tuesday, 31'st Oct 2023
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM ET Company Participants Carrie Mendivil - IR Sujal Patel - Co-Founder & CEO Parag Mallick - Co-Fou
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
08:05am, Wednesday, 11'th Oct 2023
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
08:00am, Friday, 04'th Aug 2023
SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company
Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript
01:33pm, Wednesday, 02'nd Aug 2023
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Carrie Mendivil - Investor Relations Sujal Patel - Co-Founder, Chief Executi
Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
09:23am, Tuesday, 11'th Jul 2023
SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology to Participate in Upcoming June Investor Conferences
08:05am, Wednesday, 24'th May 2023
SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company
Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
04:05pm, Tuesday, 18'th Apr 2023
SEATTLE, April 18, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will re
Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
08:00am, Thursday, 23'rd Mar 2023
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the compan
3 Penny Stocks Under $3 To Watch In March
02:17pm, Friday, 17'th Mar 2023
Penny stocks to watch right now. The post 3 Penny Stocks Under $3 To Watch In March appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Nautilus Biotechnology, Inc. (NAUT) Q4 2022 Earnings Call Transcript
03:09pm, Saturday, 25'th Feb 2023
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Sujal Patel - Co-Founder and CEO Anna Mowry - CFO Parag Mallick - Co-Foun
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
08:00am, Thursday, 26'th Jan 2023
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript
02:35pm, Tuesday, 01'st Nov 2022
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants Sujal Patel - Co-Founder and CEO Parag Mallick - Co-Founder and Chief Scie
Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference
08:00am, Tuesday, 30'th Aug 2022
SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome
